Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer

NCT01010854 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class

Stopped Premature closure for lack of efficacy.

Conditions

Interventions

Sponsor

University of California, San Francisco

Collaborators